(Q33183326)

23 July 2017

title

Determination of topotecan in human whole blood and unwashed erythrocytes by high-performance liquid chromatography (English)

1 reference

high-performance liquid chromatography

23 July 2017

1 reference

1 reference

7

Alex Sparreboom

1 reference

23 July 2017

3

Hans Gelderblom

1 reference

23 July 2017

4

Jaap Verweij

1 reference

23 July 2017

Desirée M van Zomeren

series ordinal

2

object named as

Desirée M van Zomeren

1 reference

23 July 2017

5

Kees Nooter

1 reference

23 July 2017

6

Gerrit Stoter

1 reference

23 July 2017

Walter J Loos

1

1 reference

23 July 2017

publication date

1 January 2002

1 reference

Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences

23 July 2017

published in

1 reference

23 July 2017

volume

766

1 reference

23 July 2017

issue

1

1 reference

23 July 2017

page(s)

99-105

1 reference

describes a project that uses

23 July 2017

high-performance liquid chromatography

1 reference

Role of red blood cells in pharmacokinetics of chemotherapeutic agents

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900432-7

7 January 2021

Role of erythrocytes and serum proteins in the kinetic profile of total 9-amino-20(S)-camptothecin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900432-7

7 January 2021

Gender-dependent pharmacokinetics of topotecan in adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900432-7

7 January 2021

Population pharmacokinetic model for topotecan derived from phase I clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900432-7

7 January 2021

Sensitive high-performance liquid chromatographic fluorescence assay for the quantitation of topotecan (SKF 104864-A) and its lactone ring-opened product (hydroxy acid) in human plasma and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900432-7

7 January 2021

Phase I pharmacologic study of oral topotecan and intravenous cisplatin: sequence-dependent hematologic side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900432-7

7 January 2021

Description of an instrument for separation of red cells from plasma and measurement of red cell volume

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900432-7

7 January 2021

Partitioning of ifosfamide and its metabolites between red blood cells and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900432-7

7 January 2021

Erythrocytes and the transport of drugs and endogenous compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900432-7

7 January 2021

Femtomole quantitation of 7-ethyl-10-hydroxycamptothecine (SN-38) in plasma samples by reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900432-7

7 January 2021

Quantification of topotecan and its metabolite N-desmethyltopotecan in human plasma, urine and faeces by high-performance liquid chromatographic methods

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900432-7

7 January 2021

10.1016/S0378-4347(01)00432-7

Identifiers

DOI

1 reference

23 July 2017

1 reference